Cassava Sciences

SAVA

Rank 3091

Country USA

Exchange NASDAQ

Currency USD

Sector LIFE SCIENCES

Industry PHARMACEUTICAL PREPARATIONS

Address 7801 N CAPITAL OF TEXAS HIGHWAY, SUITE 260, AUSTIN, TX, US

Cassava Sciences - Key figures

Market cap 1.06 Billion

Revenue No information

Profit -24,813,000

P/E Ratio No information

P/s Ratio -

Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases.

The company is headquartered in Austin, Texas.